LDHC and cancer: In 2016, a research team cataloged GNE-140 from a high throughput screening of two million compounds as having ability to inhibit LDHA, LDHB, and LDHC with IC50s in the nanomolar range, which could entirely block lactic acid production in cancer cells [14].